Kobayashi Pharmaceutical Co Stock Z Score
KBYPFDelisted Stock | USD 32.49 0.00 0.00% |
Kobayashi |
Kobayashi Pharmaceutical Co Company Z Score Analysis
Kobayashi Pharmaceutical's Z-Score is a simple linear, multi-factor model that measures the financial health and economic stability of a company. The score is used to predict the probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in the late 1960s at New York University..
Current Kobayashi Pharmaceutical Z Score | 5.4 |
Most of Kobayashi Pharmaceutical's fundamental indicators, such as Z Score, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Kobayashi Pharmaceutical Co is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
| |||||||
| |||||||
| |||||||
| |||||||
|
To calculate a Z-Score, one would need to know a company's current working capital, its total assets and liabilities, and the amount of its latest earnings as well as earnings before interest and tax. Z-Scores can be used to compare the odds of bankruptcy of companies in a similar line of business or firms operating in the same industry. Companies with Z-Scores above 3.1 are generally considered to be stable and healthy with a low probability of bankruptcy. Scores that fall between 1.8 and 3.1 lie in a so-called 'grey area,' with scores of less than 1 indicating the highest probability of distress. Z Score is a used widely measure by financial auditors, accountants, money managers, loan processors, wealth advisers, and day traders. In the last 25 years, many financial models that utilize z-scores proved it to be successful as a predictor of corporate bankruptcy.
CompetitionBased on the company's disclosures, Kobayashi Pharmaceutical Co has a Z Score of 5.4. This is 40.4% lower than that of the Consumer Defensive sector and 62.65% higher than that of the Household & Personal Products industry. The z score for all United States stocks is 38.07% higher than that of the company.
Did you try this?
Run Investing Opportunities Now
Investing OpportunitiesBuild portfolios using our predefined set of ideas and optimize them against your investing preferences |
All Next | Launch Module |
Kobayashi Fundamentals
Return On Equity | 0.0968 | |||
Return On Asset | 0.0633 | |||
Profit Margin | 0.12 % | |||
Operating Margin | 0.16 % | |||
Current Valuation | 3.94 B | |||
Shares Outstanding | 76.01 M | |||
Shares Owned By Insiders | 34.50 % | |||
Shares Owned By Institutions | 21.77 % | |||
Price To Earning | 34.29 X | |||
Price To Book | 2.85 X | |||
Price To Sales | 0.03 X | |||
Revenue | 155.25 B | |||
Gross Profit | 88.77 B | |||
EBITDA | 32.49 B | |||
Net Income | 19.71 B | |||
Cash And Equivalents | 116.15 B | |||
Total Debt | 596 M | |||
Debt To Equity | 0 % | |||
Current Ratio | 3.92 X | |||
Book Value Per Share | 2,653 X | |||
Cash Flow From Operations | 22.42 B | |||
Earnings Per Share | 1.94 X | |||
Number Of Employees | 3.45 K | |||
Beta | 0.27 | |||
Market Capitalization | 5.37 B | |||
Total Asset | 252.55 B | |||
Z Score | 5.4 | |||
Annual Yield | 0.01 % | |||
Net Asset | 252.55 B | |||
Last Dividend Paid | 84.0 |
About Kobayashi Pharmaceutical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Kobayashi Pharmaceutical Co's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Kobayashi Pharmaceutical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Kobayashi Pharmaceutical Co based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
EBR | Centrais Electricas Brasileiras | |
HE | Hawaiian Electric Industries | |
VFC | VF Corporation | |
BVHMF | Vistry Group PLC | |
S | SentinelOne |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Other Consideration for investing in Kobayashi Pink Sheet
If you are still planning to invest in Kobayashi Pharmaceutical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Kobayashi Pharmaceutical's history and understand the potential risks before investing.
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges |